JPH0226602B2 - - Google Patents

Info

Publication number
JPH0226602B2
JPH0226602B2 JP56125861A JP12586181A JPH0226602B2 JP H0226602 B2 JPH0226602 B2 JP H0226602B2 JP 56125861 A JP56125861 A JP 56125861A JP 12586181 A JP12586181 A JP 12586181A JP H0226602 B2 JPH0226602 B2 JP H0226602B2
Authority
JP
Japan
Prior art keywords
nitroglycerin
mineral oil
pad
solvent system
hydrophobic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56125861A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5759806A (en
Inventor
Aaru Sanboodetsukaa Deiritsupu
Jeraado Kuunii Jeemusu
Kurarensu Uesutaa Ronarudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of JPS5759806A publication Critical patent/JPS5759806A/ja
Publication of JPH0226602B2 publication Critical patent/JPH0226602B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP56125861A 1980-08-11 1981-08-11 Nitroglycerine pad for percutaneous administration Granted JPS5759806A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17704280A 1980-08-11 1980-08-11

Publications (2)

Publication Number Publication Date
JPS5759806A JPS5759806A (en) 1982-04-10
JPH0226602B2 true JPH0226602B2 (en, 2012) 1990-06-12

Family

ID=22646947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56125861A Granted JPS5759806A (en) 1980-08-11 1981-08-11 Nitroglycerine pad for percutaneous administration

Country Status (2)

Country Link
JP (1) JPS5759806A (en, 2012)
BE (1) BE889926A (en, 2012)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
FR2435950A1 (fr) * 1978-06-05 1980-04-11 Riker Laboratories Inc Pansement medical comprenant une composition a base de nitroglycerine, sa fabrication et son application

Also Published As

Publication number Publication date
JPS5759806A (en) 1982-04-10
BE889926A (fr) 1982-02-11

Similar Documents

Publication Publication Date Title
US4336243A (en) Transdermal nitroglycerin pad
JP3786684B2 (ja) オキシブチニンの経皮投与
CN1069829C (zh) 含有孕二烯酮的透皮应用的药剂
FI79467C (fi) Nytt bandage foer administrering av ett laekemedel.
US4470962A (en) Polymeric diffusion matrix
US4690683A (en) Transdermal varapamil delivery device
JPH04507256A (ja) 二相性経皮薬物供給デバイス
NZ192532A (en) Polymeric diffusion matrix and a transdermal drug delivery device
AU5240998A (en) Fatty acid esters of glycolic acid and its salts as permeation enhancers
EP0328524A1 (en) METHOD AND SYSTEM FOR TRANDSERMAL REGULATION OF FERTILITY.
JPS59155268A (ja) 薬剤注入装置
KR20020072280A (ko) 개량된 경피적 피임제 송달시스템 및 송달방법
EP0040861B1 (en) Polymeric diffusion matrix and method of its preparation
US20040202704A1 (en) Transdermal delivery systems and methods
JPH0226602B2 (en, 2012)
JPH07106978B2 (ja) 複合貼付製剤
JP2781016B2 (ja) 経皮吸収製剤
JP2001039873A (ja) 経皮吸収型排尿障害治療剤
JP2000344671A (ja) 経皮吸収貼付剤
HU183065B (en) Process for preparing a system containing polymeric matrix with prolonged release of glycerine-trinitrate